Biocon (NSE:BIOCON) Has Affirmed Its Dividend Of ₹0.50
May 12
Have your own idea? Try our Stock Screener
Indian (NIFTY) Biotech Industry Analysis
UpdatedJun 04, 2025
DataAggregated Company Financials
Companies9
- 7D-0.08%
- 3M6.2%
- 1Y21.0%
- YTD-8.5%
Over the last 7 days, the Biotech industry has remained flat, although notably Panacea Biotec declined by 16%. As for the the longer term, the industry is up 21% over the past 12 months. Looking forward, earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the Indian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 05 Jun 2025 | ₹455.2b | ₹163.8b | ₹10.6b | 47.4x | 42.8x | 2.8x |
| Sat, 03 May 2025 | ₹436.5b | ₹158.8b | ₹8.5b | 47.9x | 51.1x | 2.7x |
| Mon, 31 Mar 2025 | ₹452.4b | ₹158.8b | ₹8.5b | 49.3x | 53x | 2.8x |
| Wed, 26 Feb 2025 | ₹424.3b | ₹158.9b | ₹8.4b | 47.8x | 50.8x | 2.7x |
| Fri, 24 Jan 2025 | ₹525.3b | ₹159.6b | ₹14.5b | 57x | 36.1x | 3.3x |
| Sun, 22 Dec 2024 | ₹458.2b | ₹159.6b | ₹14.5b | 42.1x | 31.5x | 2.9x |
| Tue, 19 Nov 2024 | ₹442.0b | ₹159.6b | ₹14.5b | 39.3x | 30.4x | 2.8x |
| Thu, 17 Oct 2024 | ₹465.4b | ₹157.7b | ₹15.7b | 41.4x | 29.6x | 3x |
| Sat, 14 Sep 2024 | ₹504.3b | ₹157.7b | ₹15.7b | 36.8x | 32.1x | 3.2x |
| Mon, 12 Aug 2024 | ₹442.9b | ₹157.4b | ₹15.9b | 30.1x | 27.8x | 2.8x |
| Wed, 10 Jul 2024 | ₹473.9b | ₹157.4b | ₹10.4b | 47x | 45.7x | 3x |
| Fri, 07 Jun 2024 | ₹427.2b | ₹157.7b | ₹10.4b | 43.3x | 41.2x | 2.7x |
| Sun, 05 May 2024 | ₹394.9b | ₹155.4b | ₹12.0b | 47.7x | 32.9x | 2.5x |
| Tue, 02 Apr 2024 | ₹349.5b | ₹155.4b | ₹12.0b | 33.7x | 29.1x | 2.2x |
| Thu, 29 Feb 2024 | ₹353.1b | ₹155.4b | ₹12.0b | 38.3x | 29.4x | 2.3x |
| Sat, 27 Jan 2024 | ₹340.4b | ₹145.0b | ₹5.3b | 55.9x | 64.8x | 2.3x |
| Mon, 25 Dec 2023 | ₹324.7b | ₹145.0b | ₹5.3b | 53.7x | 61.8x | 2.2x |
| Wed, 22 Nov 2023 | ₹308.8b | ₹145.0b | ₹5.3b | 53.7x | 58.8x | 2.1x |
| Fri, 20 Oct 2023 | ₹313.0b | ₹133.7b | ₹4.8b | 37.3x | 65.9x | 2.3x |
| Sun, 17 Sep 2023 | ₹360.2b | ₹133.8b | ₹4.8b | 29.8x | 75.3x | 2.7x |
| Tue, 15 Aug 2023 | ₹332.3b | ₹133.8b | ₹4.8b | 28.1x | 69.5x | 2.5x |
| Thu, 13 Jul 2023 | ₹337.2b | ₹120.4b | ₹4.5b | 41.6x | 74.8x | 2.8x |
| Sat, 10 Jun 2023 | ₹314.4b | ₹120.8b | ₹4.5b | 40.3x | 70x | 2.6x |
| Mon, 08 May 2023 | ₹321.1b | ₹106.7b | ₹16.2b | 28.9x | 19.8x | 3x |
| Wed, 05 Apr 2023 | ₹278.9b | ₹106.6b | ₹16.4b | 20.2x | 17.1x | 2.6x |
| Fri, 03 Mar 2023 | ₹297.5b | ₹106.3b | ₹16.3b | 34.9x | 18.2x | 2.8x |
| Sun, 29 Jan 2023 | ₹314.0b | ₹99.2b | ₹18.0b | 30.2x | 17.5x | 3.2x |
| Tue, 27 Dec 2022 | ₹352.7b | ₹99.2b | ₹18.0b | 33.6x | 19.6x | 3.6x |
| Thu, 24 Nov 2022 | ₹368.1b | ₹99.2b | ₹18.0b | 34.4x | 20.5x | 3.7x |
| Sat, 22 Oct 2022 | ₹356.8b | ₹95.5b | ₹18.2b | 30.7x | 19.6x | 3.7x |
| Mon, 19 Sep 2022 | ₹383.9b | ₹95.5b | ₹18.1b | 32.7x | 21.2x | 4x |
| Wed, 17 Aug 2022 | ₹415.9b | ₹95.5b | ₹18.2b | 34.6x | 22.9x | 4.4x |
| Fri, 15 Jul 2022 | ₹433.3b | ₹92.1b | ₹17.7b | 32.2x | 24.5x | 4.7x |
| Sun, 12 Jun 2022 | ₹443.2b | ₹92.1b | ₹17.7b | 32.2x | 25.1x | 4.8x |
Price to Earnings Ratio
25.1x
Current Industry PE
- Investors are optimistic on the Indian Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 42.8x which is higher than its 3-year average PE of 39.5x.
- The industry is trading close to its 3-year average PS ratio of 3.0x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have declined 16% per year over the last three years.
- Meanwhile revenues for these companies have grown 21% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Indian Healthcare industry?
| IN Market | -0.21% | |
| Healthcare | -0.35% | |
| Biotech | -0.077% | |
| Biotech | -0.077% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BIOCON Biocon | ₹336.40 | 0.6% +₹2.5b | 10.2% | PE39.7x | |
| NIRMAN Nirman Agri Genetics | ₹250.15 | 11.7% +₹155.9m | 25.2% | PE6.9x |